InsiderTrades

Form 4 for HALO HALOZYME THERAPEUTICS, INC.

Accepted 2022-02-17 00:00:00 ET · period of report 2022-02-15 · accession 0001179110-22-001394 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-02-17 2022-02-15 HALO LaBarre Michael J. SVP, Chief Technical Off M - OptEx $0.00 +3,386 174.3K +2% $0
D 2022-02-17 2022-02-15 HALO LaBarre Michael J. SVP, Chief Technical Off F - Tax $34.43 -1,170 173.1K -0.7% -$40.3K
D 2022-02-17 2022-02-15 HALO LaBarre Michael J. SVP, Chief Technical Off M - OptEx $0.00 -3,386 10.2K -25% $0
DM 2022-02-17 2022-02-16 HALO LaBarre Michael J. SVP, Chief Technical Off A - Grant $0.00 +99.2K 74.8K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-02-15 M A 3,386 $0.00 174,307 D — —
2 Common Common Stock 2022-02-15 F D 1,170 $34.43 173,137 D — — (F1) The reported disposition of 1,170 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
3 Derivative Restricted Stock Units 2022-02-15 M D 3,386 $0.00 10,158 D $0.00 · — to — 3,386 Common Stock (F2) This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.
4 Derivative Restricted Stock Units 2022-02-16 A A 24,448 $0.00 24,448 D $0.00 · 2023-02-16 to — 24,448 Common Stock (F4) This award vests one-fourth on the first anniversary of the grant date and then one-fourth on each anniversary thereafter.
5 Derivative Option to Purchase Common Stock 2022-02-16 A A 74,777 $0.00 74,777 D $34.36 · 2023-02-16 to 2032-02-16 74,777 Common Stock (F3) This option vests one-fourth on such date and then 1/48th monthly thereafter.